7.JPG)
Global Bioinformatics Market Size is valued at USD 15.7 Billion in 2024 and is predicted to reach USD 60.3 Billion by the year 2034 at a 14.5% CAGR during the forecast period for 2025-2034.
The management and analysis of biological information using computer technology are known as bioinformatics. It involves collecting, analyzing, and sharing biological data. The field of bioinformatics uses computer algorithms to discover biological linkages, ascertain the roles of genes and proteins, and forecast the three-dimensional structures of proteins.
However, high prices for bioinformatics software and services and a shortage of experienced workers are projected to impede the bioinformatics market growth. The emergence of numerous next-generation data sets that aim to address long-standing problems regarding the biology of human diseases has intensified the current hype surrounding big data analytics' mostly untapped promise. Attempts to harness the potential of big data currently need to be improved by some important obstacles, despite the likelihood that these techniques will effectively reveal fresh biological insights.
The need for bioinformatics is rising in the global market due to rising demand for protein sequencing and nucleic acids and initiatives from public and commercial entities. The market is also fueled by a surge in molecular biology and drug delivery research, as well as the fields of genomics and proteomics. The movement of precision medicine from disorder and reductionist treatment to system-based, holistic, and beings' treatment has been made possible by advances in systems biology and pharmacogenomics.
Common challenges include the efficient evaluation of analytical software tools, the acceleration of the overall process using hybrid parallel computing (HPC) parallelization and kinetic energy technology, the development of automation strategies, data storage alternatives, and, finally, the creation of novel techniques for the full utilization of results across various experimental conditions.
The bioinformatics market is segmented based on technology & services, applications and sectors. Based on technology & services, the market is segmented as knowledge management tools (generalized knowledge management tools and specialized knowledge management tools), bioinformatics platforms (sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural analysis platforms and others), services (sequencing services, database management, data analysis and others) By applications, the market is segmented into metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatic & drug design, genomics and others. By sectors, the market is segmented into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics and others.
The platforms category is expected to hold a major share of the global bioinformatics Industry in 2022. because more platform applications are being made, drug development requires improved tools. A surge in demand from life science companies for structural health monitoring and modification may be to blame for the increase, in addition to potential. In turn, this would support the development of new drugs and the assessment of their therapeutic effects. Better drug development tools must also be created to boost the speed and safety of drug discovery and development. The increasing use of diverse tools for database administration is fueling the development of bioinformatics platforms. The extensive use of next-generation sequencing also aids the development of bioinformatics platforms. The segment is expanding due to the rising demand for exome and genome technologies.
The proteomics segment is projected to grow at a rapid rate in the global bioinformatics market. Big data analytics' unrealized potential is a feed buzz that has the expansion of R&D initiatives and significant financial investments in technology development credited with driving the proteomics market. These tools aid in the large-scale management and analysis of data. Moreover, algorithms are employed in database management and data monitoring. All these causes are driving the growth of the proteomics market.
The North American bioinformatics market is expected to register the highest market share in revenue soon. The North American bioinformatics market position is expanding due to government policies beneficial to market participants and the increasing adoption of trying-to-cut technologies. The American government is still investing in the bioinformatics industry's growth. Also, expanding R&D activities creates opportunities for regional bioinformatics market development. In addition, Asia Pacific egis projected to grow in the global Bioinformatics market demand. The need for more advanced bioinformatics tools, which are essential for medication study and development, as well as a rise in the use of cutting-edge technology, are both to blame for this because of developments in the fields of genomics and proteomics, which produce vast amounts of data that need to be processed and interpreted.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 15.7 Billion |
|
Revenue forecast in 2034 |
USD 60.3 Billion |
|
Growth rate CAGR |
CAGR of 14.50% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Mn,, and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Technology & Services, Applications And Sectors |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Agilent Technologies, Inc., Biomax Informatics Ag, Dnanexus, Inc., Genedata Ag, Intrexon Bioinformatics Germany Gmbh, Illumina, Inc., Perkinelmer, Inc., Qiagen N.V., Seven Bridges Genomics Inc., Thermo Fisher Scientific, Inc. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Bioinformatics Market Snapshot
Chapter 4. Global Bioinformatics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology & Services Estimates & Trend Analysis
5.1. by Technology & Services & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology & Services:
5.2.1. Knowledge Management Tools
5.2.1.1. Generalized Knowledge Management Tools
5.2.1.2. Specialized Knowledge Management Tools
5.2.2. Bioinformatics Platforms
5.2.2.1. Sequence Analysis Platforms
5.2.2.2. Sequence Alignment Platforms
5.2.2.3. Sequence Manipulation Platforms
5.2.2.4. Structural Analysis Platforms
5.2.2.5. Others
5.2.3. Bioinformatics Services
5.2.3.1. Sequencing Services
5.2.3.2. Database Management
5.2.3.3. Data Analysis
5.2.3.4. Others
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
6.2.1. Metabolomics
6.2.2. Molecular Phylogenetics
6.2.3. Transcriptomics
6.2.4. Proteomics
6.2.5. Chemoinformatic & Drug design
6.2.6. Genomics
6.2.7. Others
Chapter 7. Market Segmentation 3: by Sectors Estimates & Trend Analysis
7.1. by Sectors & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Sectors:
7.2.1. Medical Bioinformatics
7.2.2. Animal Bioinformatics
7.2.3. Agriculture Bioinformatics
7.2.4. Academics
7.2.5. Others
Chapter 8. Bioinformatics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Technology & Services, 2021-2034
8.1.2. North America Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.1.3. North America Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Sectors, 2021-2034
8.1.4. North America Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Technology & Services, 2021-2034
8.2.2. Europe Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.3. Europe Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Sectors, 2021-2034
8.2.4. Europe Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Technology & Services, 2021-2034
8.3.2. Asia Pacific Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Application,2021-2034
8.3.3. Asia-Pacific Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Sectors, 2021-2034
8.3.4. Asia Pacific Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Technology & Services, 2021-2034
8.4.2. Latin America Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.3. Latin America Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Sectors, 2021-2034
8.4.4. Latin America Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Technology & Services, 2021-2034
8.5.2. Middle East & Africa Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.3. Middle East & Africa Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by Sectors, 2021-2034
8.5.4. Middle East & Africa Bioinformatics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Agilent Technologies, Inc.
9.2.2. Biomax Informatics Ag
9.2.3. Dnanexus, Inc
9.2.4. Eurofins Scientific
9.2.5. Fios Genomics
9.2.6. Genedata Ag
9.2.7. Illumina Inc.
9.2.8. Intrexon Bioinformatics Germany Gmbh
9.2.9. NeoGenomics Laboratories
9.2.10. PerkinElmer Inc.
9.2.11. QIAGEN N.V.
9.2.12. Seven Bridges Genomics Inc.
9.2.13. Thermo Fisher Scientific Inc.
9.2.14. Waters Corporation
9.2.15. Other Prominent Players
Bioinformatics Market By Technology & Service
Bioinformatics Market By Application
Bioinformatics Market By Sector
Bioinformatics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
